- Monica Morrow, Chief of MSKCC’s Breast Service in the Department of Surgery, is the lead author of a study published in The Lancet that shows that MRI screening does not lead to improved outcomes for most women with breast cancer who undergo imaging prior to selecting a treatment.
- Nature reports that researchers at MSKCC have identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib, an oral targeted therapy used to treat advanced melanoma whose tumors contain a mutation in a gene called BRAF.